Advertisement

The Mode of Action of Pleuromutilin as Compared to Chloramphenicol

  • Gregor Högenauer
Conference paper
Part of the Topics in Infectious Diseases book series (TIDIS, volume 1)

Abstract

The basidomycete Pleurotus mutilis produces a substance, called pleuromutilin, which was found to be effectively inhibiting bacterial growth, mainly that of gram-positive organisms (Kavanagh et al., 1951). The structure of this compound which is an ester of glycolic acid with a tricyclic diterpene moiety, termed mutilin, had been elucidated by Arigoni’s group (Naegeli, 1961; Arigoni, 1962) and is depicted in Fig. 1,a. The antibiotic, which loses its activity if the keto group in position 3 or the hydroxy group at the carbon atom 11 are modified remains as effective as the parent compound if the exocyclic vinyl group is saturated. Moreover, if the glycolic acid side chain is substituted with thio ether derivatives the antibiotic activity can be increased by one or two orders of magnitude (Egger and Reinshagen, 1973). The water soluble derivative with the highest effect (Fig. 1,b) was used for most of the experiments reported in this article. The antibacterial spectrum of the compound extends into the gram-negative side as well. The most interesting feature of the drug is, however, its strong effect against infections by mycoplasms.

Keywords

Glycolic Acid Thio Ether Equilibrium Dialysis Magnesium Acetate Water Soluble Derivative 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations used

EF-T

elongation factor T

EF-G

elongation factor G

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. ARIGONI, D.: La structura di un terpene di nuovo genere. Gazz. chim. Ital. 92, 884–901 (1962).Google Scholar
  2. EGGER, H., and H. Reinshagen: Neue Pleuromutiline und Verfahren zu ihrer Herstellung. Ger. Offen. 2. 248, 237 (Chem. Abstr. 79, 65901 v) (1973).Google Scholar
  3. FERNANDEZ-Munoz, R., R.E. Monro, R. Torres-Pinedo, and D. Vazquez: Substrate-and Antibiotic-Binding Sites at the Peptidyl-Transferase Centre of Escherichia coli Ribosomes. Eur. J. Biochem. 23, 185–193 (1971).PubMedCrossRefGoogle Scholar
  4. KAVANAGH, F., A. Hervey, and W.J. Robbins: Antibiotic Substances from Basidomycetes. VIII. Pleurotus Multilus (FR.) Sacc. and Pleurotus Sasseckerianus Pilat. Proc. Nat. Acad. Sci. USA 37, 570–574 (1951).PubMedCrossRefGoogle Scholar
  5. LESSARD, J.L., and S. Pestka: Studies on the Formation of Transfer Ribonucleic Acid-Ribosome Complexes. J. Biol. Chem. 247, 6909–6912 (1972).PubMedGoogle Scholar
  6. NAEGELI, P.: Zur Kenntnis des Pleuromutilins. Ph. D. thesis, ETH Zürich. Juris Verlag, Zürich (1961).Google Scholar
  7. NIERHAUS, D., and K.H. Nierhaus: Identification of the ChloramphenicolBinding Protein in Escherichia coli Ribosomes by Partial Reconstitution. Proc. Nat. Acad. Sci. USA 70, 2224–2228 (1973).PubMedCrossRefGoogle Scholar
  8. NIRENBERG, M.: Cell-free Protein Synthesis Directed by Messenger RNA. Methods in Enzymology Vol. VI (Eds. S.P. Colowick and N.O. Kaplan) Academic Press, New York and London, pp. 17–23 (1963).Google Scholar

Copyright information

© Springer-Verlag/Wien 1975

Authors and Affiliations

  • Gregor Högenauer

There are no affiliations available

Personalised recommendations